News-Papers
Testimonial
Video Gallery
 | |||||
 |  |  |  |  |  |
Search
Follow us...
Latest
- Does the use of melatonin overcome drug resistance in cancer chemotherapy?
- Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
- Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
- Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
- Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms
- Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management
- Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality
- Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture
- Melatonin for the Management of Cancer-Related Fatigue in Breast Cancer: An Integrative Review
- Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer
- Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells
- Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells
- Melatonin: an ancient molecule that makes oxygen metabolically tolerable
- Molecular and cellular mechanisms of melatonin in breast cancer
- Melatonin as an adjuvant treatment modality with doxorubicin
- Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells
- Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines
- Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer